From April 28, 2023 to June 30, 2023, the company has repurchased 421,100 shares, representing 0.25% for CNY 5.07 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 CNY | +0.48% | +0.68% | -28.89% |
1st Jan change | Capi. | |
---|---|---|
-28.89% | 242M | |
+9.79% | 7.89B | |
-0.41% | 7.2B | |
-2.68% | 5.75B | |
-8.03% | 3.64B | |
-14.39% | 3.42B | |
-15.43% | 1.16B | |
-28.11% | 1.1B | |
+5.08% | 906M | |
-13.46% | 828M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.